Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO - Get Free Report) shares passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.37 and traded as low as $0.26. Northwest Biotherapeutics shares last traded at $0.30, with a volume of 4,037,524 shares changing hands.
Northwest Biotherapeutics Stock Performance
The stock has a market cap of $395.24 million, a price-to-earnings ratio of -3.81 and a beta of -0.55. The business has a 50-day simple moving average of $0.30 and a two-hundred day simple moving average of $0.37.
Northwest Biotherapeutics (OTCMKTS:NWBO - Get Free Report) last issued its quarterly earnings results on Friday, August 9th. The biotechnology company reported ($0.02) EPS for the quarter. The business had revenue of $0.51 million for the quarter.
Northwest Biotherapeutics Company Profile
(
Get Free Report)
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.
Further Reading
Before you consider Northwest Biotherapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Northwest Biotherapeutics wasn't on the list.
While Northwest Biotherapeutics currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.